Corbus Pharmaceuticals Holdings (CRBP) Non-Current Assets (2014 - 2025)

Corbus Pharmaceuticals Holdings' Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• On a quarterly basis, Non-Current Assets fell 57.25% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $8.0 million, a 42.34% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 57.25% from the prior year.
• Non-Current Assets slipped to $1.2 million in Q4 2025 per CRBP's latest filing, from $1.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $9.9 million in Q1 2021 and bottomed at $1.2 million in Q4 2025.
• The 5-year median for Non-Current Assets is $5.3 million (2023), against an average of $5.2 million.
• Across the five-year window, Non-Current Assets dropped 6.53% in 2021 and slumped 57.25% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $7.5 million in 2021, then fell by 18.53% to $6.1 million in 2022, then slipped by 22.91% to $4.7 million in 2023, then plunged by 38.57% to $2.9 million in 2024, then plunged by 57.25% to $1.2 million in 2025.
• Per Business Quant, the three latest CRBP Non-Current Assets figures stand at $1.2 million (Q4 2025), $1.9 million (Q3 2025), and $2.3 million (Q2 2025).